Jul. 01 /CSRwire/ - Originally published by Adobe
Now more than ever, we recognize that your company needs to minimize business interruption, maintain business continuity, and build resilience for the future. This is especially critical for highly regulated industries like financial services, government, as well as healthcare and life sciences. Security and compliance have never been more important, especially as employees rapidly move to working remotely.
Recently, we’ve announced new advancements in Adobe Sign that include readiness for industry standards in digital documents and e-signatures in healthcare and life sciences. These enhancements can help companies be even more productive by adopting e-signatures.
This is especially important for companies that need to comply with the US FDA regulation, 21 CFR Part 11, which oversees the use of digital documents and e-signatures in healthcare and life sciences. The business of healthcare and life sciences is highly regulated, and with these enhancements users can sign critical forms without worrying if the full digital process meets 21 CFR Part 11 requirements. This allows you to focus on helping your remote teams stay productive, not the technology.
Here’s how Adobe Sign meets the needs for health and life sciences right now:
With the newly enhanced Fill & Sign, users can select templates stored in Sign, complete their authored fields, and initiate a self-signing workflow that uses settings like identity authentication, reason for signing, and more. The entire workflow helps businesses meet compliance requirements for 21 CFR Part 11.
IT admins can use new, expanded life sciences settings in Sign to comply with 21 CFR Part 11 and work better with regulated workflows like patient consent.
We’ve also been working with Montrium, a global leader in life science compliance, to create a handbook and accelerator pack for 21 CFR Part 11 compliance documentation to get Sign customers up and running faster than ever.
Devices or locations can’t be a barrier to getting work done, whether that’s signing a document or getting feedback on a time-sensitive document. According to The Total Economic Impact of Adobe Sign, a commissioned study conducted by Forrester Consulting on behalf of Adobe in August 2019, Sign users saw a 96 percent reduction in the time it takes to get documents signed and finalized—from seven days to two hours.
“At Montrium, we believe that life sciences organizations deserve services and solutions that are as modern, well-designed, easy-to-use and accessible as the ones we use in our personal lives. Now, with the new enhancements to Adobe Sign, we’re pleased to help life sciences organizations jump-start use of e-signatures for GxP and other processes,” said Michael Zwetkow, Montrium Vice President – Professional Services & Alliances
In addition to these enhancements for life sciences, we’re continuing to invest in helping customers of all sizes and industries be more productive and secure with the broad set of tools in Sign:
Users now get even quicker access to their most recently used document templates from the home screen.
Hover-over actions in the Sign home page give users instant access to the most commonly used actions like adding a signature reminder or downloading a completed agreement.
The signing experience on mobile devices is easier than ever with optimized data entry for numbers and dates.
Learn more about signing up for a trial of Sign here. If you’re already a Sign customer, these enhancements are automatically available to you to start using today.
We recognize that technology can play a critical role by helping you enable remote work without sacrificing productivity or collaboration. We’re here to help you and your remote teams get up and running quickly in these unprecedented times. We hope that Sign can help you manage your documents and e-signatures a little easier today.
For more information, please contact:There is currently no contact information.